EVMN

7.0402.76%
LC

Luis C. Pena

Founder, President, CEO & Director

Mr. Luis C. Pena has been Founder, President, Chief Executive Officer and Director at Evommune Inc. since April 2020. He Co-founded Dermira Inc. in August 2010 and had been its Chief Development Officer since February 1, 2016. Mr. Peña served as an Executive Vice President of Product Development at Dermira Inc. from July 2013 to February 1, 2016 and served as its Vice President of Product Development from October 20, 2011 to july 2013. Mr. Peña served as Vice President of Global Portfolio Planning at Stiefel Laboratories, Inc. since April 2007. He served as a Vice President of Project Management at Connetics Corporation since August 22, 2005 and was primarily responsible for comprehensive management and support of product development programs and direct leadership of top priority projects. Mr. Peña joined Connetics from Nuvelo Inc., where he served as Vice President of Product Development since March 2001. Mr. Peña served as a Senior Director of Project Planning and Management for Theravance, Incorporated and helped to build their development organization. Prior to Theravance, Mr. Peña held various positions in manufacturing, research and development at Genentech, Inc. There he participated in the discovery of TNKase, a thrombolytic approved for the treatment of acute myocardial infarction and managed their cardiovascular development portfolio, which included TPA, TNK-TPA, VEGF and oral IIbIIIa inhibitors. Mr. Peña has broad industry experience with managing and leading development teams and programs. He serves as a Director of Dermira Inc. Mr. Peña attended the University of California, Berkeley and majored in Biochemistry. He holds a BS in Biochemistry from San Francisco State University.

Positions